去唾液酸糖蛋白受體介導的肝靶向藥物載體研究doc-資料下載頁
2025-07-17 23:56本頁面
【正文】 ial Receptor[J]. J of West China Univ of Med Sci (華西醫(yī)科大學學報), 1991,22(4):368371.[18] GUAN CT, PANG QJ, ZHONG YG, et al. The feasibility study of nga as hepatocyte targeting carrier [J]. Chin J Nucl Med (中華核醫(yī)學雜志), 1992,12 (3):166168.[19] PANG QJ, He YL, LI TL, et al. Hepatic targeting antimalarial agent: synthesis and its antimalarial activity [J].Chin J Med Chem ( 中國藥物化學雜志), 1994,14(4):240244.[20] Fan JZ, LI TL, PANG QJ, et al. Preparation of hepatic targeting antivirus agent ngaacv and its targeting property [J] Acta Pharm Sin (藥學學報), 1996, 31(8):585590.[21] GUAN CT, LI L, LI YC, et al. Studies on livertaxis of antineoplastic agent NGADHAQ and Its mechanism [J]. J Isotopes (同位素),1998,11(1):1318.[22] Jun. Ichi M, yuichi O,Tatsuro O. Possibility of application of quaternary chhosan having pendant galactose residues as gene delivery tool [J]. Carbohydro Polym, 1996,29:6974.[23] GAS SY, CHEN JN, XU XR，et al. Galactosylated low molecular weight chitosan as DNA carrier for hepatocyte targeting [J]. In J Pharm, 2003, 255:5768.[24] PARK YK, PARK YH，SHIN BA, et a1. Galactosylated chitosangraft dextran as hepatocytetargeting DNA carrier [J]. J Controlled Release, 2000, 69:97108.[25] PARK IK, KIMTH, PARK Y, et a1. Galactosylated chitosangraft poly (ethylene glycol) as hepatocyte targeting DNA Carrier [J]. J Controlled Release 2001, 76:349362.[26] PARK IK，LHM JE，PARK YH, et a1. Galactosylated chitosan(GC)graftpoly(vinyl pyrrohdone) (PVP) as hepatocytetargeting DNA Carrier [J]. J Controlled Release 2003, 86:349361.[27] ZHANG C, DING Y, SHEN and characterization of galactosylatedchitosan [J]. J of Chin Pharm Univ (中國藥科大學學報), 2003, 34(5):387390.[28] ZHANG C, JINGY, PING QN. Design, Synthesis and characterization of Ntrimethyl chitosan derivatives having pendant galactose residues [J].Chin J Mod Appl Pharm (中國現(xiàn)代應(yīng)用藥學雜志), 2005, 22(5):386388.7 / 7
范文總結(jié)相關(guān)推薦
鄂ICP備17016276號-1